General Information

We intend to target early stage North American or European companies in the biotechnology sector of the healthcare industry where our management has extensive investment and operational experience.

Our sponsor is an affiliate of 5AM Venture Management, LLC, or 5AM, a leading venture capital firm focused on building next-generation life science companies solving important healthcare needs with cutting-edge breakthroughs in medicine and science. Founded in 2002, 5AM has invested over $1.0 billion in 85 companies across biotechnology, drug delivery technology and other life sciences sectors of the healthcare industry, with 49 active investments in its portfolio.

As of August 2020, the U.S. Food and Drug Administration, or the FDA, had approved or authorized 15 products that were developed by 5AM portfolio companies, and 5AM’s portfolio companies have enrolled over 50,000 patients in more than 35 clinical trials.

Employees: 0
Founded: 2020
Contact Information
Address 501 Second Street Suite 350 San Francisco, California 94107
Phone Number (415) 993-8570
Web Address
View Prospectus: 5:01 ACQUISITION CORP.
Financial Information
Market Cap $103.6mil
Revenues $0 mil (last 12 months)
Net Income $0 mil (last 12 months)
IPO Profile
Symbol FVAM
Exchange NASDAQ
Shares (millions): 8.0
Price range $10.00 - $10.00
Est. $ Volume $80.0 mil
Manager / Joint Managers BofA Securities
Expected To Trade: 10/14/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change